Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find whether treating patients with diarrhea predominant
Irritable Bowel Syndrome (IBS) with an anti-inflammatory drug called Mesalamine will help
improve their symptoms of diarrhea, bloating and abdominal pain.